Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-040803
Filing Date
2017-11-17
Accepted
2017-11-17 17:51:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 34599
  Complete submission text file 0000000000-17-040803.txt   48284
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filed for) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations